Rosetta Genomics Interpace Diagnostics Q3 Revenues Up 38 Percent The company beat the consensus Wall Street estimate on the top line and guided to 2018 revenues of between $21 million and $22 million. Rosetta Genomics Files for Chapter 7 Bankruptcy Rosetta had disclosed that it intended to file for bankruptcy after its merger with Genoptix was not completed as planned. Rosetta Genomics Dispute With Genoptix Places Pending Merger in Jeopardy The merger, which was previously scuttled and later revived with Rosetta shareholder approval, was due to close on May 27. Rosetta Genomics Shareholders Approve Genoptix Merger Upon completion of the transaction, Rosetta will become a privately held subsidiary of Genoptix and its shares will cease to trade on the Nasdaq. Genoptix Inks Distribution Deal for Rosetta Genomics' Testing Services The deal comes as the firms try — for the second time — to close a merger that had previously failed to gain necessary approval from Rosetta shareholders. Feb 28, 2018 Rosetta Genomics, Genoptix Sign New Merger Agreement Feb 23, 2018 Rosetta Genomics, Genoptix Merger Terminated Dec 15, 2017 Genoptix to Acquire Rosetta Genomics for $10M Nov 30, 2017 Rosetta Genomics Receives Nasdaq Non-Compliance Letter Nov 8, 2017 Rosetta Genomics Receives Notification of Nasdaq Non-Compliance Oct 10, 2017 Rosetta Genomics Q2 Revenues Jump on Sales of Thyroid Assay Sep 28, 2017 Rosetta Genomics Initiates $2M Private Placement Sep 8, 2017 Rosetta Genomics Inks Deal to Sell PersonalizeDx for $2.9M Sep 5, 2017 Rosetta Genomics Announces Layoffs Aug 4, 2017 Rosetta Genomics Prices $2.7M Securities Offering May 23, 2017 Rosetta Genomics, Meir Medical Partner on microRNA Biomarker Study May 22, 2017 Rosetta Genomics Plans to Sell PersonalizeDx Business May 5, 2017 Rosetta Genomics Signs Brazilian Distribution Pact for Thyroid Test May 4, 2017 NYS Gives Final Approval for Rosetta Genomics' Thyroid Cancer Test May 2, 2017 Rosetta Genomics Realigns Strategy to Focus on Thyroid Test Mar 30, 2017 Rosetta Genomics Q4 Revenues Drop 44 Percent Mar 16, 2017 Rosetta Genomics Announces Reverse Stock Split Feb 23, 2017 Rosetta Genomics Completes Private Placement Tranche Feb 8, 2017 Rosetta Genomics Reports Q4 Sales Growth for Thyroid Nodule Test Dec 20, 2016 Rosetta Genomics Q3 Revenues Down 10 Percent Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.